Results 1 - 6 of 6
The Truth Behind Buffett's Big Bet
The Oracle of Omaha bet against top fund managers. Here's why.
4 More Companies Getting Taken Out
With merger and acquisition fever waning, which deals will work out?
PerkinElmer and ViaCell: A Bloody Good Deal?
PerkinElmer buys ViaCell for $300 million.
The bigger they are, the harder they (might) fall.
The Stocks the Funds Are Buying
Wishing is one thing. Who's buying?
Picks and Shovels of Biotechnology
CAPS players rate the best companies supporting the biotechnology and pharmaceutical industries.
Results 1 - 6 of 6